Recent Articles from Investor Brand Network

Oncotelic Therapeutics (OTCQB: OTLC) and Sapu Nano announced the expansion of its Phase 1b clinical development program for Sapu003 (Everolimus for Injection) and the appointment of Global Clinical Trials (GCT) as the lead contract research organization for international execution of Study SP-03-B101. The move follows recent regulatory approvals supporting study expansion and marks the transition of the Sapu003 program from an Australia-based clinical effort toward a broader multinational development strategy, including planned expansion into Europe.

Trident Digital Tech Holdings (NASDAQ: TDTH) announced the launch of TDTHAI, an artificial intelligence platform designed to support enterprise AI deployment, workflow automation, intelligent service delivery and digital transformation across the Asia-Pacific region. The company said the platform represents a key milestone in its evolution toward an AI-enabled digital infrastructure ecosystem spanning artificial intelligence, cybersecurity, digital identity, government technology, digital commerce and transaction-driven service platforms.

LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced definitive agreements with accredited investors for a registered direct offering expected to generate approximately $16.6 million in gross proceeds. The offering consists of 2,625,362 shares of common stock and pre-funded warrants priced at $6.31 per share, with the transaction priced at the market under Nasdaq rules. The company said the financing materially strengthens its balance sheet and provides additional flexibility to pursue strategic priorities.

TransCode Therapeutics (NASDAQ: RNAZ) announced additional results from its Phase 1a dose-escalation trial evaluating TTX-MC138, an investigational microRNA-10b inhibitor for advanced cancer. The study met its primary safety endpoint, with no dose-limiting toxicities observed across 16 patients who received a total of 86 doses. The company reported durable disease stabilization in multiple patients, including three participants who remain on treatment after 14, 16 and 21 cycles, supporting advancement of TTX-MC138 into Phase 2a clinical development.

The disruption of global oil supplies following the Strait of Hormuz closure has pushed energy costs higher across every sector, including food. Modern food systems consume up to 30% of global oil supplies, making the fossil fuel integral to the agricultural sector.

Companies making AI chips have registered a major rally in the prices of their shares, and this has added momentum to the growing debates about whether or not these surges are fueling an AI bubble that could burst anytime.

Rail Vision (NASDAQ: RVSN, FSE: C80) announced that its AI-powered ShuntingYard system has been integrated into Railserve’s newly introduced YardGUARD industrial railyard safety system, serving as a core technology within the WatchGUARD situational awareness and obstacle detection solution. The integration follows the companies’ recently announced memorandum of understanding and combines Rail Vision’s perception technology with communications and cloud-based monitoring capabilities to provide real-time visibility, obstacle detection, synchronized alerts and automatic braking support. The ShuntingYard system is being showcased this week at Railway Interchange 2026 in Omaha, Nebraska, as part of Railserve’s broader yard safety platform.

Ferrari has always been known for building powerful sports cars with strong engines, exciting performance, and a unique driving experience. For many years, the Italian company has represented luxury, speed, and tradition. However, Ferrari’s decision to introduce its first fully electric vehicle, called the Luce, has created a strong reaction from investors and car enthusiasts around the world.

A new pill can reportedly double survival in early pancreatic cancer trials, raising cautious optimism about a disease that has long resisted treatment. Revolution Medicines’ daraxonrasib targets KRAS, a gene that supplies instructions for the development of the K-Ras protein which is essentially a switch for controlling cell division, growth, and death.

BioMedWire Editorial Coverage: With oncology drug-development expenses continuing to rise and regulatory approvals becoming harder to secure, biotechnology companies are placing greater emphasis on extracting more value from existing therapies through cutting-edge delivery technologies rather than betting solely on the discovery of wholly new compounds. Across the life sciences industry, mounting interest is being directed toward nanoparticle-based platforms, intravenous reformulation strategies and precise pharmacokinetic engineering designed to potentially strengthen bioavailability, systemic exposure, tolerability and dosing reliability of established cancer medicines. Within this broader movement, Oncotelic Therapeutics Inc. (OTCQB: OTLC) ( Profile ) is advancing its Sapu003 program and Deciparticle(TM) platform as key components of a wider industry shift toward scalable nanotechnology-driven drug delivery and AI-enhanced biomedical infrastructure. The company’s approach centers on leveraging platform technologies that may serve multiple therapeutic applications across oncology and rare disease markets rather than depending on a solitary drug candidate. Oncotelic is among several companies, including CytoDyn Inc. (OTCQB: CYDY), Revolution Medicines Inc. (NASDAQ: RVMD), Moderna Inc. (NASDAQ: MRNA) and Sarepta Therapeutics Inc. (NASDAQ: SRPT), that are developing scalable biotechnology platforms designed to support multiple therapeutic programs across diverse disease areas, distinguishing…

This article has been disseminated on behalf of MAX Power Mining Corp. and may include a paid advertisement.

This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising.

Oncotelic Therapeutics (OTCQB: OTLC) was featured in a BioMedWire editorial exploring how biotechnology companies are increasingly leveraging advanced drug-delivery technologies, nanotechnology platforms and artificial intelligence to enhance existing therapies and expand treatment opportunities. The article highlights Oncotelic’s Sapu003 program, Deciparticle(TM) platform and PDAOAI initiative as part of a broader industry trend toward scalable, multi-application biotechnology platforms capable of supporting oncology and rare disease programs.

VolitionRx Limited (NYSE American: VNRX) announced the filing of a strategic patent application covering the use of its proprietary Nu.Q technology for triaging and monitoring patients suspected of having contracted the Ebola virus. The application builds on the company’s existing Nu.Q(R) NETs test, which measures circulating nucleosomes and neutrophil extracellular traps as early indicators of hyper-inflammation associated with septic shock and mortality.

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising.

Greenland Mines (NASDAQ: GRML) is expanding its position in the critical minerals sector through the advancement of its Skaergaard palladium-gold-platinum project in Greenland and its planned acquisition of the Sarfartoq neodymium-praseodymium (“NdPr”) rare-earths project. According to company disclosures, Skaergaard hosts a substantial palladium-equivalent resource and recently demonstrated significant metal-price leverage in an independent sensitivity study by SLR Consulting, while the Sarfartoq transaction would add an advanced rare-earths asset to the company’s portfolio and establish Neo Performance Materials as a strategic shareholder and future offtake partner.

FingerMotion (NASDAQ: FNGR) announced plans to expand its infrastructure strategy through the development of modular AI-focused edge computing facilities designed to support growing demand for localized artificial intelligence processing and inference workloads. The initiative builds on the company’s existing telecommunications, data and technology operations and is intended to extend its long-term infrastructure and data services roadmap.

This article has been disseminated on behalf of Canamera Energy Metals Corp. and may include paid advertising.

According to a Reuters report by Hannah Lang and Stefano Rebaudo, with additional reporting by Satoshi Sugiyama, the U.S. dollar traded in a tight range Tuesday as investors monitored developments in ongoing U.S.-Iran negotiations and the potential reopening of the Strait of Hormuz, a key global oil shipping route. Market participants remained cautious amid uncertainty surrounding the conflict and the durability of a ceasefire reached earlier this year between Washington and Tehran.

SOLOWIN HOLDINGS (NASDAQ: AXG) announced that AX Coin Bahrain B.S.C. (c), its stablecoin issuance subsidiary, has received approval from the Central Bank of Bahrain to conduct stablecoin issuer activities. The company said AX Coin is the first entity licensed under the regulator’s stablecoin framework, positioning it among a select group of stablecoin issuers operating under sovereign central bank oversight.

Alphabet Inc. (NASDAQ: GOOGL) (NASDAQ: GOOG) and other developers of health care AI systems could be affected by proposed Department of Health and Human Services rule changes that would ease longstanding requirements governing the design, testing and transparency of medical software. Supporters argue that reducing mandates for clinician testing and disclosure of training data could accelerate innovation, expand competition and lower costs for hospitals and health systems. Critics, however, warn that weakening safeguards may increase the risk of poorly designed tools entering the market, potentially creating confusion for clinicians, reducing efficiency and increasing the likelihood of medical errors. As policymakers weigh the balance between fostering innovation and protecting patient safety, the debate over how heavily AI-powered health care tools should be regulated is expected to intensify.

Perpetuals.com (NASDAQ: PDC) reported strong early adoption of its UpsideOnly trading and market prediction platform, attracting more than 30,000 active users from 185 countries and generating $4.5 billion in cumulative trading volume across 186,000 fills and 25 instruments during its first two weeks. Gold led activity with $1.4 billion in volume, followed by bitcoin at $1.2 billion, as precious metals accounted for approximately 35% of total platform trading.

Taiwan Semiconductor Manufacturing Company Ltd. (NYSE: TSM) and other semiconductor leaders are benefiting from a powerful AI-driven surge that has sent memory-chip makers such as Micron, Samsung Electronics and SK Hynix to record valuations, fueled by soaring demand for high-bandwidth memory used in data centers supporting artificial intelligence applications. While bullish investors argue that unprecedented spending by hyperscalers including Microsoft, Alphabet and Meta reflects a structural shift in computing demand that differentiates today’s market from past technology bubbles, skeptics warn that the semiconductor sector’s historically cyclical nature and rising debt-funded capital expenditures could signal overheating conditions. As investors weigh whether the rally has further room to run or is approaching a peak, the debate over whether AI enthusiasm is creating the next major market bubble continues to intensify.

Apple Inc. (NASDAQ: AAPL) and other wearable-device developers are positioned to benefit as advances in artificial intelligence and edge computing turn health care wearables into powerful clinical tools capable of delivering real-time, actionable insights rather than overwhelming streams of raw data. By continuously analyzing information collected from patients, AI-powered wearables can help clinicians identify meaningful trends, support remote patient monitoring, improve access to care in underserved areas and reduce the burden on already stretched health care professionals. While challenges remain—including the need for hospitals to modernize systems designed for episodic patient visits—the growing ability of wearables to provide a more complete picture of patient health is creating new opportunities to enhance care delivery and expand the role of connected health technologies.

Uranium Energy (NYSE American: UEC) announced that it will release its fiscal 2026 third quarter operating and financial results before the market opens on June 9, 2026. The company will host a conference call and webcast at 11:00 a.m. ET that same day to discuss the results and provide an update on operations and corporate activities.

Suntex Enterprises (OTC: SNTX) announced the closing of its previously disclosed acquisition of approximately 100 acres in South Texas through its wholly owned subsidiary, Red Spur Land & Ranch Co. Acquired for approximately $2.5 million, the property establishes a strategic land position and serves as the first major deployment of the company’s long-term development platform focused on land ownership, development, construction and infrastructure.

Oncotelic Therapeutics (OTCQB: OTLC) announced its inclusion in a BioMedWire editorial examining how biotechnology companies are increasingly focusing on advanced drug delivery technologies to enhance the effectiveness of existing cancer therapies. The article highlights growing industry interest in nanoparticle delivery systems, intravenous reformulations and precision pharmacokinetic approaches designed to improve bioavailability, systemic exposure, tolerability and dosing consistency.

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising.

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.

Oncotelic Therapeutics (OTCQB: OTLC) announced its inclusion in a BioMedWire editorial examining how biotechnology companies are increasingly focusing on advanced drug delivery technologies to enhance the effectiveness of existing cancer therapies. The article highlights growing industry interest in nanoparticle delivery systems, intravenous reformulations and precision pharmacokinetic approaches designed to improve bioavailability, systemic exposure, tolerability and dosing consistency.

Olenox Industries (NASDAQ: OLOX) reported its first monthly operating update following the acquisition of CS Digital Ventures, announcing production of approximately 18.6 bitcoin during May 2026 and an average operational hashrate of approximately 1.30 EH/s. The company said its mining fleet consists of 9,584 current-generation S21-class ASIC miners representing approximately 35 MW of installed capacity and 2.19 EH/s of nameplate hashrate, with operations currently conducted through third-party hosting facilities drawing power from the ERCOT grid.

Safe Pro Group (NASDAQ: SPAI), a developer of AI-enabled defense, security and situational awareness solutions, announced it has received a U.S. Army order for a Threat Analysis Kit that combines its edge-compute NODE platform with Red Cat Holdings’ (NASDAQ: RCAT) Black Widow(TM) drones. The order, awarded through a Defense Prime Contractor subcontract, also includes annual AI model and algorithm software upgrades, training and operational support services, with delivery expected during the second quarter of 2026.

Lantern Pharma (NASDAQ: LTRN), an AI-driven precision oncology company, reported updated Phase 2 HARMONIC trial data showing that LP-300, in combination with carboplatin and pemetrexed, demonstrated a progression-free survival benefit that increased with treatment duration in patients with EGFR Exon 21 L858R-mutant non-small cell lung cancer who had progressed following TKI therapy. The emerging data showed a median progression-free survival of 8.9 months among L858R patients treated through up to six cycles, compared with 8.4 months across the overall L858R cohort, while maintaining what the company described as an exceptionally clean safety and tolerability profile, supporting a recently FDA-cleared protocol amendment extending LP-300 dosing from six to eight cycles.

BOXABL announced its inclusion in an AINewsWire editorial examining how the U.S. housing affordability and supply crisis is driving demand for alternative construction models. The article highlights ongoing challenges including limited housing inventory, rising mortgage rates, labor shortages and increasing construction costs, which have accelerated interest in factory-built and modular housing solutions that can improve efficiency and reduce build times.

Silver has traditionally been viewed alongside gold as a safe-haven asset, attracting investors during inflationary periods and economic uncertainty. Today, however, the market is increasingly being driven by industrial consumption rather than investment demand alone.

Multinational vehicle manufacturer Stellantis has revealed plans to release 29 electric vehicle models by the end of the decade. The company behind some of the world’s largest automakers will go all in on electric vehicle development over the next 5 years to launch over two dozen EV models as part of a strategic plan designed to give Stellantis an edge in the growing electric vehicle industry.

A new viral-based vector that can be inhaled into the lungs could boost the anti-cancer response of the body in patients diagnosed with advanced lung cancer. This new treatment could also restore sensitivity to immune checkpoint inhibitors among patients that had become unresponsive.

OpenAI chief executive officer Sam Altman remarked recently that fears of AI triggering mass unemployment may have been overstated, noting that the technology hasn’t displaced office-based workers as quickly as he once expected.

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.

The rapid shift of financial services into digital spaces is creating new opportunities for cybercriminals, many of whom are increasingly relying on AI to outsmart security checks. From fabricated identities to altered documents, fraudsters are using advanced tools to bypass verification systems that many financial technology companies still struggle to secure.

Ferrari has officially entered a new chapter in its history after unveiling its first fully electric vehicle, the Luce. The luxury sports car company revealed the new model in Rome, marking a major shift for one of the world’s most famous car brands. Known for powerful gasoline engines and high-performance supercars, Ferrari is now joining the growing electric vehicle market while still trying to maintain the style and performance that made the brand popular worldwide.

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising.

BOXABL announced the launch of a beta online catalog and configurator on its developer webpage, marking a key milestone in the company’s Phase 2 growth strategy. The platform showcases a growing portfolio of residential products and reflects BOXABL’s transition from its initial Casita offering toward a broader housing system designed around standardized manufacturing technology.

American Fusion (OTC: AMFN), a company developing advanced fusion energy technologies, announced the filing of a new patent application covering innovations and design features expected to be incorporated into future commercial versions of its Texatron(TM) Fusion Engine(TM) platform following completion of Version 9 testing. The filing expands the company’s intellectual property portfolio and reflects its ongoing efforts to protect proprietary technologies as the platform advances toward commercial deployment and pre-production system design.

Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) and may include paid advertising.

Gaxos.ai (NASDAQ: GXAI) announced that Amazon Web Services (“AWS”) has committed additional funding to support development of Gaxos Labs’ AI-powered sales coaching platform, strengthening the company’s expansion into the sales technology market and advancing its strategy to build enterprise-grade artificial intelligence applications designed for commercial scalability.

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising.

Perpetuals.com (NASDAQ: PDC) reported strong early adoption of its UpsideOnly trading and market prediction platform, attracting more than 30,000 active users from 185 countries and generating $4.5 billion in cumulative trading volume across 186,000 fills and 25 instruments during its first two weeks. Gold led activity with $1.4 billion in volume, followed by bitcoin at $1.2 billion, as precious metals accounted for approximately 35% of total platform trading.

This article has been disseminated on behalf of Search Minerals Inc. and may include paid advertising.

This article has been disseminated on behalf of Optimi Health Corp. and may include paid advertising.

FingerMotion (NASDAQ: FNGR) a mobile services, data and technology company, announced a strategic evolution of its corporate direction aimed at supporting long-term growth through diversification, international expansion and emerging technology initiatives. The company said it plans to build on its telecommunications, platform and technology businesses while evaluating new opportunities designed to improve operational performance and create additional revenue streams.

Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising.

HeartBeam (NASDAQ: BEAT) a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, announced that a peer-reviewed article in JACC: Advances demonstrated that a risk prediction algorithm incorporating the credit card-sized HeartBeam ECG device can accurately identify heart attack risk in patients presenting with chest pain.

Federal regulators are moving closer to a key decision on cannabis policy as the DEA prepares to hold a hearing in June on the reclassification of marijuana under national law. The proceedings have already attracted interest from groups on both sides of the legalization debate, highlighting the continuing divide over cannabis reform in the U.S.

Xeriant (OTCQB: XERI) announced that initial certification testing for its NexBoard(TM) composite construction panel and NexPatch(TM) joint compound is scheduled to begin this week. The company also released a 30-minute internal timelapse video showing NexBoard undergoing extreme fire testing, during which the panel was exposed to sustained flame temperatures exceeding 2,000 degrees Fahrenheit without combusting or producing smoke. Xeriant said the results demonstrate the effectiveness of its proprietary intumescent fire-retardant technology as it advances the products toward third-party certification and broader commercial applications.

The Blockchain Futurist Conference 2026 is set to return to Florida on Nov. 17–18, 2026, following the success of its inaugural U.S. event. The conference will once again take the spotlight at Seminole Hard Rock Hotel & Casino Hollywood, delivering signature indoor-outdoor networking and business-development-focused experiences at the DAER Night & Day Club and DAER Rooftop venues. The 2026 event will feature expanded programming, multiple stages, an expo floor, VIP cabana networking spaces, and discussions centered on major industry topics such as stablecoins, institutional adoption, AI and Web3, tokenization, privacy, quantum security, and regulation. The conference aims to bring together thousands of attendees and the best and brightest from crypto, AI, and emerging technology sectors. ETHWomen will also return as part of the Florida event, continuing its mission to support and connect women in the Web3 space.

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.

Apptronik, an Austin-based humanoid robotics developer, has raised $520 million at a $5 billion valuation to accelerate commercialization of its Apollo humanoid robots, according to a CNBC report by Lora Kolodny. The funding round, which brings the company’s Series A financing to $935 million, was co-led by B Capital and Google and will support expanded operations, increased robot production and new facilities in Texas and California. Apollo robots are currently being tested in factory and warehouse environments with partners including Mercedes-Benz, GXO Logistics and Jabil.

BOXABL, which plans to become a publicly traded company through its proposed business combination with FG Merger II (NASDAQ: FGMC), is applying centralized manufacturing and assembly-line production techniques to residential construction in an effort to address housing affordability and supply challenges. In a June 1 SPACtrac report published by ChannelChek and Noble Capital Markets, analysts Michael Kupinski and Jacob Mutchler highlighted BOXABL’s proprietary folding-home technology, growing contract backlog of 271 units and current production capacity of approximately 3,000 units annually, with longer-term automation initiatives targeting up to 5,000 units per year. The analysts noted that the company’s factory-built housing model is designed to reduce construction timelines, improve efficiency and lower transportation costs through standardized production and logistics.

Global Mofy AI (NASDAQ: GMM), a generative AI-driven technology solutions provider focused on virtual content production and 3D digital assets, announced the pricing of an $8 million registered direct offering consisting of 8,247,420 Class A ordinary shares and accompanying Series A and Series B warrants. The securities are being offered at a combined price of $0.97 per share and accompanying warrants, with gross proceeds expected to total approximately $8 million before fees and expenses.

ParaZero Technologies (NASDAQ: PRZO), an aerospace defense company focused on autonomous solutions for manned and unmanned aerial systems, announced it has received its first order from a U.S.-based Tier-1 defense corporation for its DefendAir Net Pods. The order supports integration into advanced autonomous defense applications and marks ParaZero’s initial engagement with the major defense contractor. The company said its DefendAir system provides a non-explosive, net-based counter-drone interception capability designed for autonomous, unmanned and other defense platforms where precision and reduced collateral risk are critical, and views the order as an important step toward broader adoption of its counter-UAS technologies within the global defense market.

Apptronik, the humanoid robotics company developing its Apollo robotic platform, completed an approximately $4.2 million secondary share purchase in a transaction for which Aegis Capital Corp. acted as placement agent. Aegis acknowledged the contributions of Devin A. Heck, Michael H. Ference and Ross David Carmel of Sichenzia Ross Ference Carmel LLP, who served as legal counsel to Aegis Capital in connection with the transaction.

Aspermont (ASX:ASP) will bring together more than 2,000 mining industry participants, including over 500 executives and 100 speakers, at its co-located Future of Mining Australia and MiningNews Select conferences in Perth on June 16-17, 2026. Against a backdrop of resource nationalism, commodity supply pressures and accelerating automation, the events will focus on key industry themes including technology and innovation, energy transition, sustainability and workforce development, with speakers representing government, major mining companies, investment groups and technology organizations.

Amazon.com Inc. (NASDAQ: AMZN) and other hyperscalers are helping drive investor interest toward companies supplying the key components viewed as bottlenecks in the rapidly evolving AI ecosystem, with stock performance increasingly reflecting the importance of these critical technologies. After Nvidia’s explosive rise during a GPU shortage, attention has expanded to other constrained segments, including server CPUs, high-bandwidth memory and optical networking components, benefiting companies such as AMD, Intel, Micron, Samsung, SK Hynix, Sandisk, Lumentum, Coherent and Corning. As AI applications become more sophisticated and infrastructure demands grow, investors are increasingly seeking exposure to the suppliers of hard-to-source components that enable the industry’s expansion, betting that today’s bottlenecks could become tomorrow’s biggest winners as demand continues to outpace supply.

This article has been disseminated on behalf of Nicola Mining Inc. and may include paid advertising.

Artificial intelligence (“AI”) is transforming the way the world uses energy. From massive data centers to advanced manufacturing systems, the technologies powering the AI boom require enormous amounts of reliable electricity, putting growing pressure on existing energy infrastructure. Frontieras North America is positioning itself within that shift through its proprietary FASForm(TM) platform, which converts coal into fuels, hydrogen and industrial products, changing one of the world’s most abundant resources into a multi-output industrial energy system.

Oncotelic Therapeutics (OTCQB: OTLC) is advancing its Sapu003 program and Deciparticle platform as part of a strategy focused on improving the delivery, bioavailability and therapeutic consistency of oncology treatments. As biotechnology companies increasingly explore ways to enhance the performance of existing therapies rather than developing entirely new compounds, Oncotelic is leveraging nanotechnology-enabled drug-delivery systems and pharmacokinetic optimization to potentially improve therapeutic outcomes while reducing development risk. The company’s approach aligns with broader industry trends favoring advanced delivery technologies that may offer faster development timelines and expanded commercial opportunities.

Meta has announced plans to test new paid subscription options for its artificial intelligence tools, marking an important step in how the company wants to earn money from AI beyond advertising. The new plans will be added to the Meta AI app and website and will give users access to more powerful features for a monthly fee.

In March, legislation was tabled in the U.S. House of Representatives seeking to modify the law under which vaults are approved to store precious metals like gold, silver and platinum. A companion bill was later tabled in the Senate this month. The SILVER Act, as the legislation is called, would significantly change the existing system through which these exchange-traded precious metals are stored in the U.S.

LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced a strategic transformation into an AI energy infrastructure equipment and services platform focused on supporting the growing power demands of artificial intelligence and hyperscale data centers. As part of the transition, Stuart D. Porter, founder, managing partner, CEO and chief investment officer of Denham Capital Management LP, has joined the company’s board of directors. LIXTE said its strategy will target power equipment and service solutions for AI data-center campuses, distributed power systems and advanced generation technologies, while it seeks a strategic acquisition partner for its clinical-stage pharmaceutical and med-tech operations focused on cancer treatments.

AINewsWire Editorial Coverage : The United States housing market is facing a growing affordability and supply crisis that traditional construction methods have struggled to solve. Housing inventory remains tight across much of the country, while rising mortgage rates, labor shortages and increasing construction costs continue pushing homeownership out of reach for many Americans. Millions of homes are still needed to meet current demand, and the shortage is affecting not only major cities but suburban and rural communities as well. As affordability pressures intensify, interest is growing faster, and more scalable alternatives to conventional homebuilding. Factory-built and modular-housing models are increasingly being viewed as part of the solution because they can reduce construction time and improve efficiency. Against this backdrop, BOXABL ( Profile ) has emerged with a mission focused on producing foldable, factory-built homes designed to ship nearly anywhere and unpack quickly on-site. The company, which has signed a definitive merger agreement with FG Merger II Corp. (NASDAQ: FGMC), is positioning itself at the intersection of housing innovation, advanced manufacturing and scalable residential development. As demand for affordable housing solutions continues to rise, BOXABL’s approach reflects a broader shift toward modernizing how homes are built and delivered. The company joins an impressive group of savvy companies focused on advancing large-scale automation, artificial intelligence and next-generation manufacturing systems, including Tesla Inc. (NASDAQ: TSLA), NVIDIA Corporation (NASDAQ: NVDA), Amazon.com Inc. (NASDAQ: AMZN) and…

This article has been disseminated on behalf of MAX Power Mining Corp. and may include a paid advertisement.

BioMedWire Editorial Coverage: As oncology drug-development costs continue climbing and regulatory pathways become increasingly complex, biotechnology companies are placing renewed emphasis on improving existing therapeutics through advanced delivery technologies rather than relying exclusively on discovering entirely new drugs. Across the healthcare sector, growing attention is being directed toward nanoparticle delivery systems, intravenous reformulations and precision pharmacokinetic strategies designed to potentially improve bioavailability, systemic exposure, tolerability and dosing consistency of established cancer therapies. Within this broader movement, Oncotelic Therapeutics Inc. (OTCQB: OTLC) ( Profile ) is advancing its Sapu003 program and Deciparticle(TM) platform as part of a larger industry trend focused on scalable nanotechnology-enabled drug delivery and AI-enhanced biomedical infrastructure. The company’s strategy centers on leveraging platform technologies that may support multiple therapeutic applications across oncology and rare disease markets rather than relying solely on a single drug candidate. Oncotelic is one of several companies, including Northwest Biotherapeutics Inc. (OTCQB: NWBO), Sangamo Therapeutics Inc. (OTCQB: SGMO), HIVE Digital Technologies Ltd. (NASDAQ: HIVE) and Iovance Biotherapeutics Inc. (NASDAQ: IOVA), that are building scalable platforms — whether cancer immunotherapy, genomic medicine, AI/data infrastructure or cell therapy — rather than…